Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-09 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +30,200 30,200
2016-06-09 Selby Brian L. VP, Finance Grant or award · Stock Option (right to buy) +15,800 15,800
2016-06-09 Selby Brian L. VP, Finance Grant or award · Stock Option (right to buy) +32,100 32,100
2016-04-05 BRISTOW MICHAEL R See Remarks Sale −724 $3.52 $3K 44,610
2016-04-05 Keuer Thomas A Chief Operating Officer Sale −384 $3.52 $1K 16,097
2016-04-05 Ozeroff Christopher David S.V.P., General Counsel Sale −366 $3.52 $1K 19,585
2016-04-04 Selby Brian L. VP, Finance Sale −1,114 $3.52 $4K 3,026
2016-03-01 Keuer Thomas A Chief Operating Officer Sale −457 $3.53 $2K 16,481
2016-03-01 Ozeroff Christopher David S.V.P., General Counsel Sale −458 $3.51 $2K 19,951
2016-03-01 BRISTOW MICHAEL R See Remarks Sale −752 $3.50 $3K 45,334
2016-02-29 Selby Brian L. VP, Finance Sale −160 $3.46 $554 4,140
2016-02-11 Grais Linda S Director Grant or award · Stock Option (right to buy) +8,000 8,000
2016-02-11 Woosley Raymond L. Director Grant or award · Stock Option (right to buy) +8,000 8,000
2016-02-11 MITCHELL DANIEL J Director Grant or award · Stock Option (right to buy) +8,000 8,000
2016-02-11 CONWAY ROBERT E Director Grant or award · Stock Option (right to buy) +8,000 8,000
2015-10-16 Keuer Thomas A Chief Operating Officer Sale −496 $5.14 $3K 16,938
2015-09-18 BRISTOW MICHAEL R See Remarks Sale −1,809 $6.33 $11K 46,086
2015-09-18 Selby Brian L. VP, Finance Sale −476 $6.23 $3K 4,300
2015-09-18 Ozeroff Christopher David S.V.P., General Counsel Sale −1,129 $6.32 $7K 20,409
2015-09-18 Keuer Thomas A Chief Operating Officer Sale −680 $6.33 $4K 17,407

Page 23 of 24 · 473 trades